Clinical Presentation, and Treatment Outcomes in Tuberculous Patients in Sohag Governorate - Trial NCT06141148
Access comprehensive clinical trial information for NCT06141148 through Pure Global AI's free database. This phase not specified trial is sponsored by Sohag University and is currently Recruiting. The study focuses on Tuberculosis. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sohag University
Timeline & Enrollment
N/A
Nov 01, 2023
Dec 30, 2024
Primary Outcome
percent of cured tuberculous patients,percent of treatment failure
Summary
Tuberculosis (TB) is an infectious disease that commonly affects the lung and is caused by a
 bacterium called Mycobacterium Tuberculosis. The bacterium mostly affects people with
 impaired immunity TB becomes the second leading cause of morbidity and mortality among
 infectious diseases, following the emergence of the human immunodeficiency virus (HIV). HIV
 is the commonest risk factor for developing a life-threatening tuberculosis disease, on the
 other hand, HIV related immunodeficiency is worsened by TB infection.TB is among the top 10
 causes of death worldwide. In2019, among 8.8 million adults who developed TB disease, 36%
 were women .TB has become the fifth leading cause of death among women.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06141148
Non-Device Trial